Frequently asked questions

  • Are there any contraindications?

For safety reasons, rTMS cannot be administered to patients with intracranial metallic devices (coils, shunt valves) or electrical bodily implants. Nor can it be performed in patients with uncontrolled epilepsy. Before starting treatment a doctor will assess whether there are contraindications on a case-by-case basis.

  • Is it useful in all types of aphasia?

According to the published scientific literature, the treatment is most effective in patients with motor aphasia (non-fluent) or in those cases of overall aphasia with motor predominance. After the initial medical and speech-language pathology assessment we will inform you whether the characteristics of your aphasia will benefit from treatment. We are currently treating patients with this technique starting six months after the injury. Although it is primarily aimed at people who have suffered a stroke, it may also be indicated for other causes of acquired brain damage.

  • Is rTMS safe?

According to reliable clinical application guidelines (see article published by the Safety of TMS Consensus Group, Clin Neurophysiol, 2009), TMS is a safe technique. The possibility of suffering from a seizure is remote, especially when considering the stimulation patterns used in our protocol. Some patients may experience a mild headache or passing cervical discomfort.

  • Do I need to stop my regular speech-language pathology treatment?

The treatment is completely compatible with any speech-language pathology treatment you may be undergoing before and after the intensive two-week treatment programme.

  • Can another stimulation cycle be repeated in the future?

The possibility of repeating treatment may be considered on an individual basis. Suitability will be assessed on a case-by-case basis at the subsequent medical follow-up visit.